Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders

被引:70
作者
Chew, NYK
Bagster, DF
Chan, HK
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Chem Engn, Sydney, NSW 2006, Australia
基金
澳大利亚研究理事会;
关键词
amorphous powders; aerosol inhaler; particle size; air flow; disodium cromoglycate;
D O I
10.1016/S0378-5173(00)00516-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler(R) and Dinkihaler(R); connected to a four-stage liquid impinger operating at 30-120 1/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 mu m and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm(3) and moisture content of 6.6 wt.%. Using Rotahaler(R), the maximum fine particle fraction (FPFmax) for all three powders was only 15 wt.%, attained at the highest flow of 120 1/min. Using Dinkihaler(R), the FPFmax was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 mu m powder, respectively, at 60 1/min; and 18 wt.% for the 5.2 mu m powder at 120 1/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 25 条
[1]  
[Anonymous], AEROSOLS MED PRINCIP
[2]  
BELL JH, 1973, J PHARM PHARMACOL, V25, pP96
[3]   Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger [J].
Braun, MA ;
Oschmann, R ;
Schmidt, PC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) :53-62
[4]   Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery [J].
Chan, HK ;
Clark, A ;
Gonda, I ;
Mumenthaler, M ;
Hsu, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :431-437
[5]   Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols [J].
Chew, NYK ;
Chan, HK .
PHARMACEUTICAL RESEARCH, 1999, 16 (07) :1098-1103
[6]   THE RELATIONSHIP BETWEEN POWDER INHALER RESISTANCE AND PEAK INSPIRATORY CONDITIONS IN HEALTHY-VOLUNTEERS - IMPLICATIONS FOR IN-VITRO TESTING [J].
CLARK, AR ;
HOLLINGWORTH, AM .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1993, 6 (02) :99-110
[7]  
CORN M, 1996, AEROSOL SCI, P359
[8]   SOLID-STATE CHEMISTRY OF CROMOLYN SODIUM (DISODIUM-CROMOGLYCATE) [J].
COX, JSG ;
WOODARD, GD ;
MCCRONE, WC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (10) :1458-&
[9]   Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers .2. Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers [J].
deBoer, AH ;
Gjaltema, D ;
Hagedoorn, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 138 (01) :45-56
[10]   The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation [J].
French, DL ;
Edwards, DA ;
Niven, RW .
JOURNAL OF AEROSOL SCIENCE, 1996, 27 (05) :769-783